Progenitor Cell Therapy Continues Expansion
Complete the form below to unlock access to ALL audio articles.
Progenitor Cell Therapy, LLC (PCT) has announced that it has completed construction of additional Class 10,000 clean room space at its manufacturing facility in Mountain View, California.
"In the past three months, we designed and constructed additional new Class 10,000 clean rooms to meet the growing demand for PCT’s cell therapy contract manufacturing services," said Stewart Craig Ph.D., PCT’s Chief Technology Officer and Vice President.
"We are now qualifying this space and are pleased to be completing our second phase of expansion after finishing the first phase in late 2005."
"Over the past nine months, we have increased the clean room manufacturing capacity of this facility by approximately 80% and are already in the design phase for a further doubling of our clean room space, product development capacity, and associated support areas."
"We continue to strategically position our core business to meet the demands of the maturing cell therapy industry," said Robert A. Preti Ph.D., President and Chief Scientific Officer of PCT.
"Our success is built on the interactive partnering approach we take with clients to provide them with customized solutions that meet their development and manufacturing needs."
"With a world-recognized team of experts in the field, PCT can offer clients rapid responses and solutions to their specific needs."
